Testosterone replacement therapy is one of the most searched and most misunderstood topics in men's health. Searched by men who are exhausted, struggling to maintain muscle, experiencing low libido, brain fog or mood changes — and wondering whether declining testosterone is the reason. This is an honest explanation of what TRT is, what it is not, who it is genuinely for, and what to do before you decide.
Testosterone replacement therapy means supplementing the body's own testosterone production with exogenous testosterone — testosterone from outside the body. It is prescribed when a physician determines that a patient's testosterone levels are clinically low and that this deficiency is causing symptoms that impair quality of life.
In the UK, TRT is a prescription-only medicine. The forms most commonly prescribed are testosterone undecanoate (Nebido — a long-acting injection given every 10-14 weeks), testosterone enanthate or cypionate (shorter-acting injections given weekly or fortnightly), and transdermal gels applied daily. Each has different pharmacokinetic profiles, and the choice between them depends on individual response, preference and prescriber judgment.
TRT is clinically indicated for hypogonadism — a medical condition in which the body produces insufficient testosterone. Primary hypogonadism is caused by testicular failure. Secondary hypogonadism is caused by failure of the hypothalamic-pituitary axis to signal testosterone production adequately.
Symptoms of clinically low testosterone include: persistent fatigue and reduced energy, significant loss of muscle mass despite training, low libido and erectile dysfunction, depression, anxiety and mood instability, reduced bone density, and cognitive changes including concentration and memory difficulties.
The important qualifier is that these symptoms are nonspecific — they overlap with thyroid disorders, anaemia, sleep apnoea, depression, chronic stress and a dozen other conditions. Symptoms alone are not sufficient to justify TRT. The diagnosis requires blood work confirming low testosterone alongside clinical symptoms.
Before any reputable physician will prescribe TRT, they will require at minimum: total testosterone (tested in the morning, fasted, as levels peak in early AM), LH and FSH (to distinguish primary from secondary hypogonadism), SHBG (sex hormone binding globulin — affects how much testosterone is biologically active), oestradiol, full blood count, and a metabolic panel.
The British Society for Sexual Medicine (BSSM) guidelines suggest that total testosterone below 12 nmol/L combined with consistent symptoms warrants consideration of treatment. Below 8 nmol/L is considered clearly deficient. Many men with symptoms have levels in the 10-15 nmol/L range — which is where clinical judgment and patient experience become significant factors.
A single low reading is not sufficient. Two morning measurements taken at least four weeks apart are typically required before a diagnosis is made.
NHS prescribing for TRT is available but can be difficult to access. GPs vary significantly in their willingness to investigate and treat low testosterone — some are proactive, many are not. The process typically involves a GP referral to an endocrinologist or urologist, which can involve significant waiting times.
Private TRT clinics have grown significantly in the UK over the past decade. Providers including Balance My Hormones, Leger Clinics, and various private GP practices offer testosterone testing and prescribing, typically with faster access and more flexible prescribing frameworks. Costs range from £100-200/month including medication and monitoring.
The important distinction: a reputable clinic will require blood work before prescribing, will monitor regularly, and will not prescribe to someone with normal testosterone simply because they want optimisation. Be cautious of any provider who prescribes without proper diagnostic blood work.
TRT restores testosterone to normal physiological levels. It is not a performance-enhancing intervention in the same sense as supraphysiological steroid use. Men with genuinely low testosterone who reach normal range typically notice significant improvements in energy, mood, libido and body composition — because they are restoring something deficient.
Men with testosterone already in the normal range who add TRT are doing something different — and that is outside the scope of medical TRT. The distinction matters both medically and legally.
TRT also suppresses the body's own testosterone production. The HPT axis (hypothalamic-pituitary-testicular) responds to exogenous testosterone by reducing LH output, which reduces testicular stimulation. This causes testicular atrophy over time and affects fertility. This is why gonadorelin or HCG are often used alongside TRT — to maintain testicular function.
Several peptides are directly relevant to men on TRT and are documented on this platform. Gonadorelin maintains HPT axis function and testicular size during TRT. BPC-157 supports connective tissue and gut health — relevant because long-term TRT can affect these systems. GHK-Cu supports collagen synthesis and tissue quality. The full TRT companion protocol is available to platform members — covering the peptide additions that address TRT's known side effects and support long-term health during therapy.
We'll email you when we publish something new. Free, no account needed, unsubscribe anytime.
Full TRT blood work calendar, gonadorelin protocol and peptide companion guide — available to members.